82 related articles for article (PubMed ID: 17595800)
1. Evaluation of late neurologic adverse events in patients with brain metastases from non-small cell lung cancer.
Nieder C; Astner ST; Grosu AL; Molls M
Anticancer Res; 2007; 27(3B):1701-4. PubMed ID: 17595800
[TBL] [Abstract][Full Text] [Related]
2. Motexafin gadolinium combined with prompt whole brain radiotherapy prolongs time to neurologic progression in non-small-cell lung cancer patients with brain metastases: results of a phase III trial.
Mehta MP; Shapiro WR; Phan SC; Gervais R; Carrie C; Chabot P; Patchell RA; Glantz MJ; Recht L; Langer C; Sur RK; Roa WH; Mahe MA; Fortin A; Nieder C; Meyers CA; Smith JA; Miller RA; Renschler MF
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1069-76. PubMed ID: 18977094
[TBL] [Abstract][Full Text] [Related]
3. Two radiation regimens and prognostic factors for brain metastases in nonsmall cell lung cancer patients.
Rades D; Schild SE; Lohynska R; Veninga T; Stalpers LJ; Dunst J
Cancer; 2007 Sep; 110(5):1077-82. PubMed ID: 17614294
[TBL] [Abstract][Full Text] [Related]
4. Survival and neurologic outcomes in a randomized trial of motexafin gadolinium and whole-brain radiation therapy in brain metastases.
Mehta MP; Rodrigus P; Terhaard CH; Rao A; Suh J; Roa W; Souhami L; Bezjak A; Leibenhaut M; Komaki R; Schultz C; Timmerman R; Curran W; Smith J; Phan SC; Miller RA; Renschler MF
J Clin Oncol; 2003 Jul; 21(13):2529-36. PubMed ID: 12829672
[TBL] [Abstract][Full Text] [Related]
5. Primary chemotherapy for newly diagnosed nonsmall cell lung cancer patients with synchronous brain metastases compared with whole-brain radiotherapy administered first : result of a randomized pilot study.
Lee DH; Han JY; Kim HT; Yoon SJ; Pyo HR; Cho KH; Shin SH; Yoo H; Lee SH; Lee JS
Cancer; 2008 Jul; 113(1):143-9. PubMed ID: 18459180
[TBL] [Abstract][Full Text] [Related]
6. Does the incidence and outcome of brain metastases in locally advanced non-small cell lung cancer justify prophylactic cranial irradiation or early detection?
Carolan H; Sun AY; Bezjak A; Yi QL; Payne D; Kane G; Waldron J; Leighl N; Feld R; Burkes R; Keshavjee S; Shepherd F
Lung Cancer; 2005 Jul; 49(1):109-15. PubMed ID: 15949596
[TBL] [Abstract][Full Text] [Related]
7. A randomised phase III study of palliative radiation with concomitant carboplatin for brain metastases from non-small cell carcinoma of the lung.
Guerrieri M; Wong K; Ryan G; Millward M; Quong G; Ball DL
Lung Cancer; 2004 Oct; 46(1):107-11. PubMed ID: 15364138
[TBL] [Abstract][Full Text] [Related]
8. Long-term survival in patients with synchronous, solitary brain metastasis from non-small-cell lung cancer treated with radiosurgery.
Flannery TW; Suntharalingam M; Regine WF; Chin LS; Krasna MJ; Shehata MK; Edelman MJ; Kremer M; Patchell RA; Kwok Y
Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):19-23. PubMed ID: 18280058
[TBL] [Abstract][Full Text] [Related]
9. The use of recursive partitioning analysis grouping in patients with brain metastases from non-small-cell lung cancer.
Gülbaş H; Erkal HS; Serin M
Jpn J Clin Oncol; 2006 Apr; 36(4):193-6. PubMed ID: 16611661
[TBL] [Abstract][Full Text] [Related]
10. Comparison of short-course versus long-course whole-brain radiotherapy in the treatment of brain metastases.
Rades D; Bohlen G; Dunst J; Lohynska R; Veninga T; Stalpers L; Schild SE; Dahm-Daphi J
Strahlenther Onkol; 2008 Jan; 184(1):30-5. PubMed ID: 18188520
[TBL] [Abstract][Full Text] [Related]
11. Gamma knife radiosurgery for multiple brain metastases from lung cancer.
Park SH; Hwang SK; Kang DH; Lee SH; Park J; Hwang JH; Hamm IS; Park YM
J Clin Neurosci; 2009 May; 16(5):626-9. PubMed ID: 19268596
[TBL] [Abstract][Full Text] [Related]
12. Value of whole brain re-irradiation for brain metastases--single centre experience.
Sadikov E; Bezjak A; Yi QL; Wells W; Dawson L; Millar BA; Laperriere N
Clin Oncol (R Coll Radiol); 2007 Sep; 19(7):532-8. PubMed ID: 17662582
[TBL] [Abstract][Full Text] [Related]
13. Results of the whole-brain radiotherapy for patients with brain metastases from lung cancer: the RTOG RPA intra-classes analysis.
Kepka L; Cieslak E; Bujko K; Fijuth J; Wierzchowski M
Acta Oncol; 2005; 44(4):389-98. PubMed ID: 16120548
[TBL] [Abstract][Full Text] [Related]
14. [Mangement of brain metastases based on EBM].
Narita Y
Gan To Kagaku Ryoho; 2005 Apr; 32(4):463-7. PubMed ID: 15853211
[TBL] [Abstract][Full Text] [Related]
15. Systemic chemotherapy after cranial irradiation in patients with brain metastases from non-small cell lung cancer: a retrospective study.
Kim JH; Kim HS; Kwon JH; Park S; Kim HY; Jung JY; Kim HJ; Song HH; Lee GW; Lee SI; Gong SJ; Lee JA; Kim KJ; Zang DY
Lung Cancer; 2009 Mar; 63(3):405-9. PubMed ID: 18621432
[TBL] [Abstract][Full Text] [Related]
16. Treatment of brain metastases from non-small-cell lung cancer (NSCLC): radiotherapy.
Zabel A; Debus J
Lung Cancer; 2004 Aug; 45 Suppl 2():S247-52. PubMed ID: 15552806
[TBL] [Abstract][Full Text] [Related]
17. Whole-brain radiotherapy with 20 Gy in 5 fractions for brain metastases in patients with cancer of unknown primary (CUP).
Rades D; Bohlen G; Lohynska R; Veninga T; Stalpers LJ; Schild SE; Dunst J
Strahlenther Onkol; 2007 Nov; 183(11):631-6. PubMed ID: 17960339
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of 2 whole-brain radiotherapy schedules and prognostic factors for brain metastases in breast cancer patients.
Rades D; Lohynska R; Veninga T; Stalpers LJ; Schild SE
Cancer; 2007 Dec; 110(11):2587-92. PubMed ID: 17893909
[TBL] [Abstract][Full Text] [Related]
19. Phase III study of efaproxiral as an adjunct to whole-brain radiation therapy for brain metastases.
Suh JH; Stea B; Nabid A; Kresl JJ; Fortin A; Mercier JP; Senzer N; Chang EL; Boyd AP; Cagnoni PJ; Shaw E
J Clin Oncol; 2006 Jan; 24(1):106-14. PubMed ID: 16314619
[TBL] [Abstract][Full Text] [Related]
20. A new scoring system to predicting the survival of patients treated with whole-brain radiotherapy for brain metastases.
Rades D; Dunst J; Schild SE
Strahlenther Onkol; 2008 May; 184(5):251-5. PubMed ID: 18427755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]